X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2067) 2067
Publication (109) 109
Newspaper Article (49) 49
Book Review (28) 28
Newsletter (15) 15
Magazine Article (4) 4
Conference Proceeding (2) 2
Transcript (2) 2
Book / eBook (1) 1
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1531) 1531
nausea (1488) 1488
index medicus (1287) 1287
female (1075) 1075
male (995) 995
adult (863) 863
middle aged (795) 795
vomiting (678) 678
patients (567) 567
aged (527) 527
pain (435) 435
oncology (423) 423
cancer (421) 421
treatment outcome (396) 396
nausea - chemically induced (385) 385
clinical trials (358) 358
chemotherapy (330) 330
medicine (301) 301
immunology (298) 298
surgery (297) 297
adolescent (283) 283
diarrhea (272) 272
care and treatment (270) 270
research article (269) 269
analysis (267) 267
young adult (233) 233
safety (223) 223
multidisciplinary sciences (222) 222
science (222) 222
health aspects (221) 221
studies (209) 209
medical research (204) 204
vomiting - chemically induced (202) 202
research (196) 196
nausea - etiology (183) 183
double-blind (182) 182
side effects (179) 179
therapy (178) 178
toxicity (176) 176
drug therapy (175) 175
hematology (174) 174
anesthesiology (173) 173
medicine & public health (172) 172
prevention (172) 172
prospective studies (171) 171
fatigue (170) 170
anesthesia (162) 162
double-blind method (157) 157
pharmacology (155) 155
child (154) 154
children (152) 152
risk factors (152) 152
aged, 80 and over (149) 149
efficacy (149) 149
retrospective studies (146) 146
infectious diseases (145) 145
headache (143) 143
diagnosis (140) 140
complications and side effects (139) 139
pharmacology & pharmacy (138) 138
drug dosages (137) 137
medicine and health sciences (136) 136
abridged index medicus (135) 135
hospitals (131) 131
management (131) 131
fever (128) 128
quality of life (125) 125
infections (123) 123
animals (121) 121
drug administration schedule (121) 121
antiemetics - therapeutic use (119) 119
confidence intervals (118) 118
medicine, experimental (117) 117
dose-response relationship, drug (116) 116
pharmacokinetics (116) 116
medicine, general & internal (115) 115
pediatrics (114) 114
transplantation (109) 109
gastroenterology & hepatology (108) 108
pregnancy (107) 107
systematic review (107) 107
dexamethasone (106) 106
internal medicine (106) 106
antineoplastic agents - adverse effects (105) 105
biology and life sciences (105) 105
dosage and administration (105) 105
survival (104) 104
tumors (104) 104
adults (102) 102
drugs (102) 102
diabetes (101) 101
trial (100) 100
cancer therapies (99) 99
drug therapy, combination (98) 98
metastasis (98) 98
signs and symptoms (98) 98
abdomen (97) 97
analgesics (96) 96
randomization (96) 96
usage (96) 96
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2091) 2091
Chinese (29) 29
Spanish (11) 11
German (4) 4
French (2) 2
Italian (2) 2
Portuguese (2) 2
Hungarian (1) 1
Japanese (1) 1
Korean (1) 1
Norwegian (1) 1
Romanian (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 11, p. e13540
Although HAART suppresses HIV replication, it is often unable to restore immune homeostasis. Consequently, non-AIDS-defining diseases are increasingly seen in... 
INFECTED INDIVIDUALS | KAPOSIS-SARCOMA | HLA-DR | CELLULAR RESERVOIRS | ACTIVE ANTIRETROVIRAL THERAPY | CLINICAL-TRIALS | BIOLOGY | GENE-EXPRESSION | CYNOMOLGUS MONKEYS | PERIPHERAL-BLOOD | HUMAN-IMMUNODEFICIENCY-VIRUS | T-Lymphocytes, Regulatory - metabolism | Prospective Studies | Humans | Middle Aged | AIDS Vaccines - immunology | Male | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | Killer Cells, Natural - immunology | Adult | Female | tat Gene Products, Human Immunodeficiency Virus - immunology | HIV-1 - metabolism | Immunization - adverse effects | Immunization - methods | Lymphocyte Activation | HIV Infections - virology | Homeostasis - immunology | Treatment Outcome | Combined Modality Therapy | Antiretroviral Therapy, Highly Active | HIV-1 - immunology | B-Lymphocytes - immunology | Nausea - etiology | Asthenia - etiology | HIV Infections - therapy | Aged | CD8-Positive T-Lymphocytes - immunology | Antiviral agents | Immunization | Genes | Development and progression | Hostages | Disease susceptibility | HIV (Viruses) | Gene expression | Infection | Proteins | Highly active antiretroviral therapy | Lymphocytes | Analysis | Health aspects | Laboratories | CD8 antigen | Homeostasis | Viruses | Lymphocytes T | Activation | Macrophages | Cell activation | Reduction | Immunology | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | CD38 antigen | Human immunodeficiency virus--HIV | Physiology | Telomerase | Immune system | Antigens | Immunological memory | Memory cells | Immune response | Immunoregulation | Dermatology | Glycoproteins | Virology | CD4 antigen | Tat protein | Monocytes | Infectious diseases | Lymphocytes B | Stem cells | Replication | Histocompatibility antigen HLA | Regulatory proteins | Apoptosis | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 12/2006, Volume 194, Issue 12, pp. 1638 - 1649
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 11, p. e13983
Background: We conducted a Phase I randomized, dose-escalation, route-comparison trial of MVA-CMDR, a candidate HIV-1 vaccine based on a recombinant modified... 
BOOST VACCINE | PRIME | T-CELL RESPONSES | IMMUNE-RESPONSES | DNA | BIOLOGY | SMALLPOX VACCINATION | HUMAN-IMMUNODEFICIENCY-VIRUS | NYVAC-C | HIV-1 VACCINE | SUBTYPE-B | HIV Infections - prevention & control | Headache - etiology | Human Immunodeficiency Virus Proteins - immunology | Immunity, Humoral - immunology | United States | Humans | AIDS Vaccines - immunology | Fatigue - etiology | Male | Vaccination - adverse effects | Thailand | Vaccinia virus - genetics | Dose-Response Relationship, Drug | HIV Infections - immunology | Flow Cytometry | Immunity, Cellular - drug effects | Vaccination - methods | Recombination, Genetic | Adult | Female | Injections, Intradermal | Enzyme-Linked Immunosorbent Assay | Injections, Intramuscular | HIV-1 - genetics | Genetic Vectors - genetics | Immunity, Cellular - immunology | HIV-1 - immunology | Nausea - etiology | Immunity, Humoral - drug effects | Human Immunodeficiency Virus Proteins - genetics | AIDS Vaccines - administration & dosage | AIDS vaccines | Analysis | Vaccination | Clinical trials | T cells | HIV (Viruses) | Health aspects | Vaccinia | Antibodies | Lymphocytes T | Vaccines | Dosage | Assaying | Gene sequencing | Randomization | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | Peripheral blood mononuclear cells | Safety | Enzyme-linked immunosorbent assay | Recombinant | Binding | Good Manufacturing Practice | Immune response (cell-mediated) | Health risks | T cell receptors | Immune response (humoral) | CD4 antigen | Immunogenicity | γ-Interferon | Glycoprotein gp120 | Cytokines | Corticotropin-releasing hormone | Risk factors | Infection | Gag protein | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 2009, Volume 27, Issue 31, pp. 4104 - 4109
Abstract A Phase 1 study was conducted in 24 malaria naïve adults to assess the safety and immunogenicity of the recombinant protein vaccine apical membrane... 
Allergy and Immunology | Malaria | Falciparum | Apical membrane antigen 1 | APICAL MEMBRANE ANTIGEN-1 | MEDICINE, RESEARCH & EXPERIMENTAL | CONTROLLED-TRIAL | EFFICACY | PROTECTION | NORMAL VOLUNTEERS | AMA1 VACCINE | IMMUNOLOGY | PLASMODIUM-FALCIPARUM MALARIA | CHILDREN | IN-VITRO | ANTIBODY-PRODUCTION | Oligodeoxyribonucleotides - administration & dosage | Adjuvants, Immunologic - administration & dosage | Adjuvants, Immunologic - pharmacology | Antigens, Protozoan - immunology | Humans | Middle Aged | Male | Aluminum Hydroxide - administration & dosage | Plasmodium falciparum - immunology | Vaccines, Synthetic - immunology | Young Adult | Antibodies, Protozoan - blood | Vaccines, Synthetic - adverse effects | Malaria Vaccines - adverse effects | Malaria Vaccines - immunology | Adult | Female | Immunization Schedule | Vaccines, Subunit - adverse effects | Aluminum Hydroxide - pharmacology | Membrane Proteins - immunology | Vaccines, Subunit - immunology | Chemistry, Pharmaceutical | Malaria - prevention & control | Animals | Malaria Vaccines - administration & dosage | Vaccines, Subunit - administration & dosage | Adolescent | Vaccines, Synthetic - administration & dosage | Oligodeoxyribonucleotides - pharmacology | Protozoan Proteins - immunology | Proteins | Hepatitis | Headaches | Nausea | Vaccines | Family medical history | Drug dosages | Blood | Fever
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2015, Volume 33, Issue 32, pp. 3759 - 3765
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 8, p. e11995
Background: A peptide vaccine was produced containing B and T cell epitopes from the V3 and C4 Envelope domains of 4 subtype B HIV-1 isolates (MN, RF, CanO, &... 
ENVELOPE PEPTIDES | NEUTRALIZING ANTIBODIES | RHESUS-MONKEYS | SAFETY | VACCINE | BIOLOGY | SYNTHETIC PEPTIDES | GP120 | HUMAN-IMMUNODEFICIENCY-VIRUS | CYTOTOXIC T-LYMPHOCYTES | ADJUVANT | HIV-1 | Antibody Formation - immunology | Immunization - adverse effects | Immunization - methods | Humans | Middle Aged | Peptides - immunology | Abscess - etiology | Oleic Acids | Male | Vaccines, Subunit - immunology | Freund's Adjuvant - immunology | Mannitol - analogs & derivatives | Young Adult | Adolescent | Adult | Female | T-Lymphocytes - immunology | Vaccines, Subunit - adverse effects | Peptides - adverse effects | Antigen-antibody reactions | Highly active antiretroviral therapy | Immunization | AIDS vaccines | Immune response | Peptides | Abscess | Development and progression | HIV (Viruses) | T cells | Antigenic determinants | Headache | CD8 antigen | Cytotoxicity | Lymphocytes T | Vaccines | Assaying | B7 antigen | Chills | Pain | Acquired immune deficiency syndrome--AIDS | Cryopreservation | Human immunodeficiency virus--HIV | Enzyme-linked immunosorbent assay | Antigens | Risk groups | Risk reduction | Adjuvants | Nausea | Epitopes | Myalgia | CD4 antigen | Immunogenicity | Lymphocytes B | Freund's adjuvant | Abscesses | Histocompatibility antigen HLA | Manganese | Neutralization | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Blood, ISSN 0006-4971, 01/2011, Volume 117, Issue 3, pp. 788 - 797
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 11/2016, Volume 13, Issue 1, p. 281
Background: Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) are present in a subset of aquaporin-4 (AQP4)-IgG-negative patients with optic neuritis... 
Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) | Myelitis | Myelin oligodendrocyte glycoprotein (MOG) antibodies | Respiratory insufficiency | Optic neuritis | Cerebellitis | Intractable nausea and vomiting | MOG-IgG | Rhombencephalitis | Facial nerve palsy | Hearing loss | Diplopia Internuclear ophthalmoplegia (INO) | Ataxia | Neuromyelitis optica spectrum disorders (NMOSD) | Brainstem encephalitis | Longitudinally extensive transverse myelitis (LETM) | IMMUNOLOGY | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | ACUTE DISSEMINATED ENCEPHALOMYELITIS | EXTENSIVE TRANSVERSE MYELITIS | AQUAPORIN-4 ANTIBODY | INTERFERON-BETA | CLINICAL-COURSE | NEUROSCIENCES | LESIONS | OPTICA SPECTRUM DISORDERS | NEUROMYELITIS-OPTICA | DIAGNOSTIC-CRITERIA | Myelin-Oligodendrocyte Glycoprotein - immunology | Neuromyelitis Optica - drug therapy | Age Factors | Immunoglobulin G - blood | Encephalitis - diagnostic imaging | Humans | Middle Aged | Male | Neuromyelitis Optica - immunology | Interferon-beta - therapeutic use | Young Adult | Rituximab - therapeutic use | Myelitis - immunology | Adult | Female | Disability Evaluation | Brain Stem - diagnostic imaging | Myelitis - blood | Myelitis - pathology | Encephalitis - immunology | Neuromyelitis Optica - blood | Neuromyelitis Optica - diagnostic imaging | Blood-Brain Barrier - pathology | Magnetic Resonance Imaging | Adolescent | Brain Stem - physiopathology | Encephalitis - blood | Cohort Studies | Prevention | Immunoglobulin G | Immunotherapy | Influence | Brain damage | Research | Health aspects | Myelin proteins | Risk factors
Journal Article